AXGN

#4287
Axogen, Inc. - Common Stock
0.3 9 USD
-99.02%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
0.39
0.39
Faixa anual
0.39
45.75
Mudança diária
-99.02%
Mudança mensal
-99.07%
Mudança em 6 meses
-98.64%
Mudança anual
-97.84%
Fechamento anterior
40.4 2
Open
0.3 9
Mínimo
0.3 9
High
0.3 9
Volume
121
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 20.99 M
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Dispositivos médicos
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-96.26
Índice preço/fluxo de caixa
6.69

Axogen, Inc. - Common Stock

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Notícias